Nanofibrous Vildagliptin-Eluting Stents Enhance Re-Endothelialization And Reduce Neointimal Formation In Diabetes: In Vitro And In Vivo [Corrigendum]

Lee CH, Hsieh MJ, Chang SH, et al. Int J Nano. 2019;14:7503–7513. The authors noticed a mistake in the published paper which was overlooked during the revision stages. On page 7511, in the Acknowledgments section, the sentence “… Chang Gung M...

Full description

Bibliographic Details
Main Authors: Lee CH, Hsieh MJ, Chang SH, Hung KC, Wang CJ, Hsu MY, Juang JH, Hsieh IC, Wen MS, Liu SJ
Format: Article
Language:English
Published: Dove Medical Press 2019-12-01
Series:International Journal of Nanomedicine
Online Access:https://www.dovepress.com/httpswwwdovepresscomcorrigendum-nanofibrous-vildagliptin-eluting-stent-peer-reviewed-article-IJN
id doaj-4362d81c770a46c4901c73455604f282
record_format Article
spelling doaj-4362d81c770a46c4901c73455604f2822020-11-25T02:28:48ZengDove Medical PressInternational Journal of Nanomedicine1178-20132019-12-01Volume 149793979450390Nanofibrous Vildagliptin-Eluting Stents Enhance Re-Endothelialization And Reduce Neointimal Formation In Diabetes: In Vitro And In Vivo [Corrigendum]Lee CHHsieh MJChang SHHung KCWang CJHsu MYJuang JHHsieh ICWen MSLiu SJLee CH, Hsieh MJ, Chang SH, et al. Int J Nano. 2019;14:7503–7513. The authors noticed a mistake in the published paper which was overlooked during the revision stages. On page 7511, in the Acknowledgments section, the sentence “… Chang Gung Memorial Hospital (Contract No. CMRPG3G1291) for financially supporting this research.” should read “… Chang Gung Memorial Hospital (Contract No. CMRPG3G1291 and CMRPG3G1292) for financially supporting this research.” The authors apologize for this oversight.Read the original articlehttps://www.dovepress.com/httpswwwdovepresscomcorrigendum-nanofibrous-vildagliptin-eluting-stent-peer-reviewed-article-IJN
collection DOAJ
language English
format Article
sources DOAJ
author Lee CH
Hsieh MJ
Chang SH
Hung KC
Wang CJ
Hsu MY
Juang JH
Hsieh IC
Wen MS
Liu SJ
spellingShingle Lee CH
Hsieh MJ
Chang SH
Hung KC
Wang CJ
Hsu MY
Juang JH
Hsieh IC
Wen MS
Liu SJ
Nanofibrous Vildagliptin-Eluting Stents Enhance Re-Endothelialization And Reduce Neointimal Formation In Diabetes: In Vitro And In Vivo [Corrigendum]
International Journal of Nanomedicine
author_facet Lee CH
Hsieh MJ
Chang SH
Hung KC
Wang CJ
Hsu MY
Juang JH
Hsieh IC
Wen MS
Liu SJ
author_sort Lee CH
title Nanofibrous Vildagliptin-Eluting Stents Enhance Re-Endothelialization And Reduce Neointimal Formation In Diabetes: In Vitro And In Vivo [Corrigendum]
title_short Nanofibrous Vildagliptin-Eluting Stents Enhance Re-Endothelialization And Reduce Neointimal Formation In Diabetes: In Vitro And In Vivo [Corrigendum]
title_full Nanofibrous Vildagliptin-Eluting Stents Enhance Re-Endothelialization And Reduce Neointimal Formation In Diabetes: In Vitro And In Vivo [Corrigendum]
title_fullStr Nanofibrous Vildagliptin-Eluting Stents Enhance Re-Endothelialization And Reduce Neointimal Formation In Diabetes: In Vitro And In Vivo [Corrigendum]
title_full_unstemmed Nanofibrous Vildagliptin-Eluting Stents Enhance Re-Endothelialization And Reduce Neointimal Formation In Diabetes: In Vitro And In Vivo [Corrigendum]
title_sort nanofibrous vildagliptin-eluting stents enhance re-endothelialization and reduce neointimal formation in diabetes: in vitro and in vivo [corrigendum]
publisher Dove Medical Press
series International Journal of Nanomedicine
issn 1178-2013
publishDate 2019-12-01
description Lee CH, Hsieh MJ, Chang SH, et al. Int J Nano. 2019;14:7503–7513. The authors noticed a mistake in the published paper which was overlooked during the revision stages. On page 7511, in the Acknowledgments section, the sentence “… Chang Gung Memorial Hospital (Contract No. CMRPG3G1291) for financially supporting this research.” should read “… Chang Gung Memorial Hospital (Contract No. CMRPG3G1291 and CMRPG3G1292) for financially supporting this research.” The authors apologize for this oversight.Read the original article
url https://www.dovepress.com/httpswwwdovepresscomcorrigendum-nanofibrous-vildagliptin-eluting-stent-peer-reviewed-article-IJN
work_keys_str_mv AT leech nanofibrousvildagliptinelutingstentsenhancereendothelializationandreduceneointimalformationindiabetesinvitroandinvivocorrigendum
AT hsiehmj nanofibrousvildagliptinelutingstentsenhancereendothelializationandreduceneointimalformationindiabetesinvitroandinvivocorrigendum
AT changsh nanofibrousvildagliptinelutingstentsenhancereendothelializationandreduceneointimalformationindiabetesinvitroandinvivocorrigendum
AT hungkc nanofibrousvildagliptinelutingstentsenhancereendothelializationandreduceneointimalformationindiabetesinvitroandinvivocorrigendum
AT wangcj nanofibrousvildagliptinelutingstentsenhancereendothelializationandreduceneointimalformationindiabetesinvitroandinvivocorrigendum
AT hsumy nanofibrousvildagliptinelutingstentsenhancereendothelializationandreduceneointimalformationindiabetesinvitroandinvivocorrigendum
AT juangjh nanofibrousvildagliptinelutingstentsenhancereendothelializationandreduceneointimalformationindiabetesinvitroandinvivocorrigendum
AT hsiehic nanofibrousvildagliptinelutingstentsenhancereendothelializationandreduceneointimalformationindiabetesinvitroandinvivocorrigendum
AT wenms nanofibrousvildagliptinelutingstentsenhancereendothelializationandreduceneointimalformationindiabetesinvitroandinvivocorrigendum
AT liusj nanofibrousvildagliptinelutingstentsenhancereendothelializationandreduceneointimalformationindiabetesinvitroandinvivocorrigendum
_version_ 1724836309726396416